
HORIBA, Ltd.
HORIBA
HORIBA, Ltd. is the Japanese instrument maker that owns two markets most analysts do not connect: it is the dominant supplier of mass flow controllers and gas analysis systems to the semiconductor industry, and through its HORIBA Jobin Yvon division it is one of the world's leading manufacturers of Raman and fluorescence spectrometers. Founded in 1945 and headquartered in Kyoto, the company reported net sales of JPY 333,081 million in 2025, up 5.0 percent, with operating income of JPY 53,040 million and an operating margin of 15.9 percent. Consolidated employees numbered 9,101 at the end of 2025, and the first half of 2026 accelerated sharply: six-month net sales reached JPY 179,853 million, up 20.8 percent, with operating income up 39.3 percent.
The company's origins are in automotive emission measurement, a business it still leads through systems used by vehicle manufacturers and regulators worldwide. It has since diversified into environmental monitoring instruments, scientific analysers, medical diagnostic analysers and semiconductor measuring equipment. The HORIBA Jobin Yvon optical division traces its heritage to a French grating manufacturer founded in 1819, which is why the group's most advanced spectroscopy manufacturing sits in Longjumeau, France rather than in Japan.
Strengths: Position in semiconductor mass flow controllers, where HORIBA's instruments meter the process gases used in wafer fabrication and are specified into tool platforms by equipment makers, giving the company a stake in every semiconductor capacity expansion. Optical spectroscopy leadership through HORIBA Jobin Yvon, a business with a two-century lineage in diffraction gratings that manufactures its own optical components and Raman systems at Longjumeau. Automotive emission measurement, where HORIBA systems are used for regulatory certification testing by vehicle and engine manufacturers, a franchise that renews as emissions rules tighten in each market. Dual-region manufacturing spanning Japan and France, which insulates the group from single-country supply risk in both Asia and Europe. Accelerating momentum in 2026, with first-half sales up 20.8 percent and operating income up 39.3 percent on semiconductor materials and research spectroscopy demand.
Weaknesses: Smaller than every other company in this ranking at JPY 333 billion of sales, which limits research spending against competitors several times its size. Heavy dependence on semiconductor capital spending, the most cyclical end market in the industry, through both mass flow controllers and process gas analysis. Limited presence in the highest-value analytical categories, since HORIBA does not compete in high-field nuclear magnetic resonance, electron microscopy or high-resolution mass spectrometry. Automotive exposure, where emission measurement revenue is tied to vehicle development budgets and powertrain transition schedules that are themselves in flux. Modest scale in life science instruments relative to the diagnostic and bioprocessing franchises held by larger competitors.Read MoreShow Less
The company's origins are in automotive emission measurement, a business it still leads through systems used by vehicle manufacturers and regulators worldwide. It has since diversified into environmental monitoring instruments, scientific analysers, medical diagnostic analysers and semiconductor measuring equipment. The HORIBA Jobin Yvon optical division traces its heritage to a French grating manufacturer founded in 1819, which is why the group's most advanced spectroscopy manufacturing sits in Longjumeau, France rather than in Japan.
Strengths: Position in semiconductor mass flow controllers, where HORIBA's instruments meter the process gases used in wafer fabrication and are specified into tool platforms by equipment makers, giving the company a stake in every semiconductor capacity expansion. Optical spectroscopy leadership through HORIBA Jobin Yvon, a business with a two-century lineage in diffraction gratings that manufactures its own optical components and Raman systems at Longjumeau. Automotive emission measurement, where HORIBA systems are used for regulatory certification testing by vehicle and engine manufacturers, a franchise that renews as emissions rules tighten in each market. Dual-region manufacturing spanning Japan and France, which insulates the group from single-country supply risk in both Asia and Europe. Accelerating momentum in 2026, with first-half sales up 20.8 percent and operating income up 39.3 percent on semiconductor materials and research spectroscopy demand.
Weaknesses: Smaller than every other company in this ranking at JPY 333 billion of sales, which limits research spending against competitors several times its size. Heavy dependence on semiconductor capital spending, the most cyclical end market in the industry, through both mass flow controllers and process gas analysis. Limited presence in the highest-value analytical categories, since HORIBA does not compete in high-field nuclear magnetic resonance, electron microscopy or high-resolution mass spectrometry. Automotive exposure, where emission measurement revenue is tied to vehicle development budgets and powertrain transition schedules that are themselves in flux. Modest scale in life science instruments relative to the diagnostic and bioprocessing franchises held by larger competitors.
Listed market data
6856 · TSE · weeklyHistory →- Market cap
- $6.2 B
- Share price
- JPY 21655.00
- 1Y change
- +50.8%
- Recent change
- -1.7%
- Since first close
- +72.7%
- Revenue (TTM)
- JPY$333 B (FY2025)
10-30 → 11-02
from 2025-09
Financial history
Full market history- 2026-11JPY 21655.00$6.2 B-1.7%
- 2026-10JPY 22035.00$6.3 B-9.9%
- 2026-09JPY 24445.00$7 B+4.2%
- 2026-08JPY 23465.00$6.7 B-8.6%
- 2026-07JPY 25675.00$7.3 B-6.3%
- 2026-06JPY 27410.00$7.8 B+4.4%
- 2026-05JPY 26265.00$7.5 B+21.0%
- 2026-04JPY 21700.00$6.2 B+21.5%
- 2026-03JPY 17865.00$5.1 B-15.1%
- 2026-02JPY 21045.00$6 B+14.9%
- 2026-01JPY 18315.00$5.2 B+14.8%
- 2025-12JPY 15960.00$4.6 B—
Ownership & Control
Shareholding as of 2022-06-30- Controlling entity
- Publicly held — no controlling shareholder disclosed
- Company type
- Brand & Manufacturer
- Insiders
- 9.34%
- Institutions
- 51.05%(177 holders)
- Free float
- 56.31%
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →5 latest headlines1- Atsushi Horiba OBE, Chairman & Group CEO of HORIBA, Ltd., Named Honorary Fellow of University College London - AZoMwww.azom.com2026-09-29
- Horiba Targets ¥20B India Revenue by 2028 with Local R&D - Rediff MoneyWizmoney.rediff.com2026-09-14
- HORIBA, Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 - www.marketscreener.comwww.marketscreener.com2026-08-07
- HORIBA: 2028 targets raised with focus on growth, R&D, sustainability, and enhanced shareholder returns - TradingViewwww.tradingview.com2026-07-31
- Fujifilm, Horiba Unveil New Inline Raman System - Spectroscopy Onlinewww.spectroscopyonline.com2026-06-19
• Mass flow controllers and process gas analysers
• Moisture monitoring and vaporisation systems
Optical Spectroscopy – HORIBA Jobin Yvon, ruling its own gratings since 1819
• Raman and fluorescence spectrometers
• Diffraction gratings and monochromators made in-house
• ICP emission spectrometers and X-ray fluorescence analysers
Automotive Emission Measurement – regulatory certification franchise
• Vehicle and engine emission test systems
• Engine test cell and dynamometer control systems
Environmental & Medical Instruments – monitoring and clinical analysers
• Water quality, ambient air and stack gas analysers
• Clinical chemistry and coagulation analysers
Service & Laboratory Support – calibration, application labs and service
• Instrument calibration, validation and testing support
• Application laboratories, method development and service
Quick Facts
Headquarters
Kyoto, Japan
Founded
1945
Employees
9,101
Revenue
JPY$333 B (FY2025)
Market cap
$6.2 B
Factories
Core plants in Kyoto and Shiga, Japan, plus optical manufacturing in Longjumeau, France, and an assembly base in Shanghai, China
Presence
Subsidiaries and branch offices across more than 30 countries in Asia, Europe and the Americas
Listing
TSE Prime : 6856
Categories
16 categories · scroll for more
Related
Similar listed companies
- Merck & Co., Inc.· $369 B
- Thermo Fisher Scientific Inc.· $258 B
- The Linde Group· $237 B
- Siemens AG· $235 B
- KLA· $206 B
- Abbott Laboratories· $185 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website TSE Prime : 6856 , HORIBA — Official Website · Company Profile · FY2025 Consolidated Financial Statements · H1 2026 Consolidated Financial Statements
